Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00061126
What this trial is testing

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Who this might be right for
Prostate Cancer
Abgenix 50
Not applicableStudy completedNCT03896984
What this trial is testing

Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Bayer 346
Not applicableEnded earlyNCT02491411
What this trial is testing

Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Early research (Phase 1)Ended earlyNCT01510288
What this trial is testing

Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Amsterdam UMC, location VUmc 28
Testing effectiveness (Phase 2)Study completedNCT02012296
What this trial is testing

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Chicago 88
Testing effectiveness (Phase 2)Study completedNCT00541281
What this trial is testing

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Who this might be right for
Hormone Resistant Prostate CancerMetastatic Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150
Not applicableStudy completedNCT02907372
What this trial is testing

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPCa)
Centre Francois Baclesse 163
Large-scale testing (Phase 3)Study completedNCT00110214
What this trial is testing

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 1,050
Post-approval studies (Phase 4)Study completedNCT00434447
What this trial is testing

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Who this might be right for
Bone Neoplasms
Novartis Pharmaceuticals 73
Early research (Phase 1)Study completedNCT03076203
What this trial is testing

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneStage IV Prostate AdenocarcinomaHormone-refractory Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Large-scale testing (Phase 3)Active Not RecruitingNCT05204927
What this trial is testing

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate
Curium US LLC 439
Not applicableStudy completedNCT03122743
What this trial is testing

Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerRecurrent Prostate CarcinomaStage I Prostate Cancer+3 more
Wake Forest University Health Sciences 61
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Early research (Phase 1)Study completedNCT01144897
What this trial is testing

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

Who this might be right for
Castrate Resistant Prostate CancerProstate Cancer
Daniel Vaena 5
Not applicableNo Longer AvailableNCT01516762
What this trial is testing

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer
Testing effectiveness (Phase 2)Study completedNCT03899467
What this trial is testing

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Suzhou Kintor Pharmaceutical Inc, 61
Testing effectiveness (Phase 2)UnknownNCT01630967
What this trial is testing

Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Neoplasm
British Columbia Cancer Agency 40
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Post-approval studies (Phase 4)Active Not RecruitingNCT03016741
What this trial is testing

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+2 more
Northwestern University 100
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Next Page